FDA Lacks Legal Sway To Enforce AER Label Revisions – Attorney
This article was originally published in The Tan Sheet
Executive SummaryThere is little chance FDA will aggressively enforce changes to dietary supplement and OTC drug labels recommended in the adverse event report labeling guidance, a food and drug attorney says
You may also be interested in...
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.